Latest Trypanosoma cruzi Stories
ABBOTT PARK, Ill., May 19 /PRNewswire-FirstCall/ -- Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test.
Another test to detect Trypanosoma cruzi infection SILVER SPRING, Md., April 30 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a second test to screen blood, tissue and organ donors for a blood-borne parasite, Trypanosoma cruzi (T.
It makes your skin crawlâ€”a bug that crawls onto your lips while you sleep, drawn by the exhaled carbon dioxide, numbs your skin, bites, then gorges on your blood.
A team of researchers from McGill/MUHC validates a novel screening tool in the fight against Chagas disease.
The first systematic study of surveillance techniques for the insect vector of Chagas disease in Amazonia concludes that tall palm trees with large amounts of debris on their crowns and stems should be targets for disease surveillance and control.
The parasite Trypanosoma cruzi (or T cruzi), which causes Chagasâ€™ disease, will go to great lengths to evade death once it has infected human host cells, researchers have discovered.
RARITAN, N.J., Dec. 13 /PRNewswire/ -- Ortho-Clinical Diagnostics, a Johnson & Johnson company, announced today that the U.S.
Nearly 20 million people worldwide are infected with a parasitic ailment called Chagas Disease, and nearly a third of those will develop severe heart trouble. Although options for treatment are poor and there are no vaccines, a new study by scientists at the University of Georgia of proteins in the parasite that causes the disease may offer hope.